Home

Horn Messenger Hopeful peg asparaginase allergic reaction log Serious road

Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment  in contemporary paediatric acute lymphoblastic leukaemia protocols: a  meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect

Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia. -  Abstract - Europe PMC
Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia. - Abstract - Europe PMC

ASPARLAS (calaspargase pegol-mknl) Dosing
ASPARLAS (calaspargase pegol-mknl) Dosing

Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute  lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective  single-center study | Scientific Reports
Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports

Algorithm for treatment with PEG-asparaginase (* = mean number of vials). |  Download Scientific Diagram
Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram

(PDF) Alternative algorithm for L-asparaginase allergy in children with  acute lymphoblastic leukemia | Selin Aytac - Academia.edu
(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu

Asparaginase - Wikipedia
Asparaginase - Wikipedia

Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity  Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia  - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha,  Belinda N. Mandrell, 2018
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018

Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic  leukemia: immunology and clinical consequences | Future Oncology
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology

Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic  leukemia: immunology and clinical consequences | Future Oncology
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology

Pharmacokinetics of very prolonged PEGasparaginase and Erwinia... |  Download Scientific Diagram
Pharmacokinetics of very prolonged PEGasparaginase and Erwinia... | Download Scientific Diagram

A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in  Adult Patients with Acute Lymphoblastic Leukemia
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia

Managing toxicities with asparaginase-based therapies in adult ALL: summary  of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect

Managing asparaginase-related toxicity in adult patients - Oncology Nurse  Advisor
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor

Detecting and Treating Asparaginase-Related Toxicities in Acute  Lymphoblastic Leukemia (Transcript)
Detecting and Treating Asparaginase-Related Toxicities in Acute Lymphoblastic Leukemia (Transcript)

Proposed treatment algorithm after allergic reactions to front-line... |  Download Scientific Diagram
Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram

Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or  Intramuscular Asparaginase Agents
Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents

How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia  | Future Oncology
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia | Future Oncology

Cost-analysis of treatment of childhood acute lymphoblastic leukemia with  asparaginase preparations: the impact of expensive chemotherapy |  Haematologica
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy | Haematologica

AEA measurements and 95% CI over time in the groups; Allergic reaction... |  Download Scientific Diagram
AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram

Increase in peg-asparaginase clearance as a predictor for inactivation in  patients with acute lymphoblastic leukemia | Leukemia
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia

Bubble plot of the incidence of allergic reactions (sum of allergies... |  Download Scientific Diagram
Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram

PEG - Aspraginaz - Zuvius Lifesciences
PEG - Aspraginaz - Zuvius Lifesciences

Increase in peg-asparaginase clearance as a predictor for inactivation in  patients with acute lymphoblastic leukemia | Leukemia
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia

ASPARLAS (calaspargase pegol-mknl) Dosing
ASPARLAS (calaspargase pegol-mknl) Dosing

Overall (A), induction (B) and postinduction (C) incidence of allergic... |  Download Scientific Diagram
Overall (A), induction (B) and postinduction (C) incidence of allergic... | Download Scientific Diagram